LXCHEM Laxmi Organic Industries Q3 FY26 results (Oct–Dec 2025) and concall
Laxmi Organic reported a challenging Q3 FY26 with a 9% revenue decline and 33% EBITDA drop year-on-year, primarily due to price moderation in Specialties and subdued spreads in Essentials. Despite the headwinds, the company is progressing with its Dahej expansion, with Phase 2 completion targeted by Q4 FY26, and its Lote fluorination facility is on track. Management highlighted early green shoots in raw material pricing and a continued focus on self-help measures and new growth projects.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue down 8.5%, net profit down 13.8% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 771 | 786 | 710 | 693 | 700 −9% | 719 −9% |
| EBITDA | 75 | 75 | 59 | 31 | 37 −51% | 50 −33% |
| Net profit | 28 | 29 | 22 | 21 | 11 −61% | 25 −14% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
